Mary Claire Haver HRT Recommendations: What She Uses, What Guidelines Say, and How to Get Them

This independent article is not affiliated with or endorsed by Dr. Haver.
Mary Claire Haver HRT recommendations center on estradiol (she prefers a patch), progesterone protection for women with a uterus using systemic estrogen, and vaginal estrogen for local symptoms, chosen with a clinician who reviews your history. Her own routine adds extras, like off-label testosterone and routine estradiol blood tests, that go further than standard guidelines.
This page is for you if you've read or heard Dr. Haver and want to know which parts of her advice fit you, how they line up with medical guidance, and where you can actually get care if you can't see her.
- Ask about the core, not the whole list. These are well-supported options for the right symptoms and medical history—not a three-drug package everyone needs. Guidance is most favorable for systemic HRT near menopause when there are no contraindications. Her other items are choices she ties to her own labs and goals. (The Menopause Society)
- Start in person first if you have unexplained vaginal bleeding, a past blood clot, stroke or heart attack, breast or uterine cancer, or liver disease.
- Can't see her? Her clinic treats Texas residents only. Her website points other women to Midi and Alloy for online menopause care. We compare those, plus Gala and your own doctor. See where to get each piece →
The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.
We may earn a commission if you start care through some links on this page, including Gala. That doesn't change what we report. This is an independent explanation, not Dr. Haver's website. How we make money.
What we actually verified · Last verified October 2026
We read (October 15, 2026): Dr. Haver's posts on what she takes (updated August 6, 2026), her hormone-therapy basics page (updated March 19, 2026), her March 3, 2026 essay on estradiol testing, her June 16, 2026 podcast show notes, her clinic's website and FAQ, and her list of telehealth services; a May 2025 interview; FDA announcements and product labeling; The Menopause Society's 2022 position statement; the British Menopause Society's paper on estradiol measurements; an ISSWSH testosterone guideline; ACOG's own October 15 announcement about its new guidance; and Gala, Alloy and Midi's public HRT and pricing pages.
We confirmed in those documents: her reported routine and stated reasons; her clinic's Texas-resident restriction and no-insurance model; Midi and Alloy's presence on her site; Gala's advertised $69-a-month HRT plan and listed medication options; and the provider-published prices below. The cost examples show their assumptions rather than treating an unknown as free.
We did not: speak with Dr. Haver or her clinic, sign up for any service, or receive care. This is a review of public documents, not a patient test.
We could not confirm: the exact finished products Gala dispenses, which medication combinations its $69 price covers, required lab charges, its HRT-specific age/state list or exact renewal schedule; an applicable HRT cancellation agreement that resolves its conflicting wording; the price of a visit at Dr. Haver's clinic; or each reader's final Alloy bundle. We did not read the full new ACOG guideline; we used its official announcement only for the points it explains.
On this page: At a glance · The Translator · What she takes · Should you copy it? · Where to get it · 90-day cost · Patch and progesterone · Blood tests · Testosterone · Vaginal estrogen, estriol and DHEA · What HRT can't promise · Your situation · Appointment worksheet · Quick answers
Mary Claire Haver HRT recommendations at a glance
Dr. Haver's core advice is body-identical estradiol, progesterone protection for women with a uterus using systemic estrogen, and vaginal estrogen for vaginal and urinary symptoms, started after a real talk with a clinician about benefits and risks. Her own routine goes further, and she says plainly that it isn't a plan for everyone to copy.
Dr. Mary Claire Haver's clinic identifies her as a board-certified OB-GYN and a Menopause Society Certified Practitioner (MSCP), a credential earned through The Menopause Society's exam in menopause care. She wrote The New Menopause and The New Perimenopause, hosts the unPAUSED podcast, runs The 'Pause Life website and founded a Galveston, Texas clinic now called The 'Pause Wellness. Her appeal is easy to understand: she talks plainly about a stage of life that can feel lonely. (The 'Pause Life, E142 bio; The 'Pause Wellness)
A few words we'll use:
- HRT means hormone replacement therapy, also called menopause hormone therapy (MHT).
- Estradiol is the main form of estrogen your ovaries made before menopause.
- Systemic treatment travels through your whole body. Pills, patches, gels and sprays are systemic. They treat hot flashes and night sweats.
- Local treatment works mostly where you put it, like low-dose vaginal estrogen. Some vaginal products are systemic, so the exact product matters.
- Progestogen is the umbrella word for progesterone and similar medicines that protect the uterine lining.
Here's her approach sorted into three buckets.
| Bucket | What's in it | What it means for you |
|---|---|---|
| The core | Estradiol (her main one is a patch); uterine protection with systemic estrogen; vaginal estrogen for local symptoms | Standard, well-supported options for the right person—not a package everyone needs. A reasonable thing to ask about. |
| Her personal extras | A small oral estradiol dose added after testing; testosterone gel used off-label; estriol face cream; a vulvar DHEA product | Choices tied to her labs and goals. Worth a question, not a request. |
| What she warns against | Testosterone pellets; testosterone doses far above the normal female range | Ask directly whether anything you're offered is a pellet or compounded. |
Source: The 'Pause Life, "Breaks Down Everything She Actually Takes", June 26, 2026, updated August 6, 2026; The ABCs of Hormone Therapy, updated March 19, 2026.
The Haver Recommendation Translator: her advice vs. the guidelines
Much of Dr. Haver's core advice lines up with established menopause guidance when treatment fits the symptoms and medical history. The benefit-risk balance for systemic HRT is generally most favorable under 60 or within 10 years of menopause, without contraindications. She goes further on routine estradiol blood tests, testosterone for bone and muscle, and cosmetic estriol. Those uses need their own evidence, not just confidence in the person recommending them. (The Menopause Society; ACOG)
We built this table so you can see each piece in one place: what she says, what major guidance says, whether the product is FDA-approved, and the one question that matters most. Start with the row that matches what you came here wondering about. You don't have to solve every hormone question before you book a visit.
| What she recommends or uses | Her view (source, date) | What standard guidance says | Product status in the U.S. | Agrees or goes further? | Don't assume… | Ask your clinician |
|---|---|---|---|---|---|---|
| 1. Timing | Emphasizes starting near menopause without contraindications; may still be an option after 60 with careful discussion (ABCs, Mar 2026) | TMS 2022 and ACOG's Oct 2026 announcement favor starting before 60 or within 10 years of natural menopause when treatment is appropriate and there are no contraindications | — | Agrees | …that after 60 means "never" or "always fine" | "Given my age and time since my last period, how do benefits and risks look for me?" |
| 2. Estradiol patch as the main estrogen | Generic patch twice a week; steady dose; avoids the liver's first-pass processing (blog, Jun 2026) | Skin-route estrogen may carry lower clot risk; route is chosen per person (TMS) | FDA-approved patches exist, brand and generic | Agrees | …that a patch is right for everyone or risk-free | "Why would a patch, gel, spray or pill fit me best?" |
| 3. A small oral estradiol dose added | Added after her blood levels on the patch alone were below the level she wanted for bone protection; she says it's specific to her labs (blog, Jun 2026) | Dose, form and route set individually and reviewed over time (TMS 2022) | FDA-approved oral estradiol exists | Her personal extra | …that two estrogen routes is a better standard plan | "How will we judge whether my dose is working?" |
| 4. Routine estradiol blood tests | Argues checking levels after starting should be standard; openly disagrees with guidelines (Substack, Mar 3, 2026) | TMS 2022: serum hormone testing "rarely needed"; saliva/urine tests unreliable | A lab test, not a drug | Goes further | …that one number proves protection or the right dose | "Would checking my level change what you'd do? Who pays?" |
| 5. Progesterone with a uterus | Oral micronized progesterone; discusses alternatives including vaginal use, a hormonal IUD, CombiPatch or Duavee (blog and E142, Jun 2026) | Systemic estrogen needs adequate uterine-lining protection. A progestogen usually supplies it; the specific conjugated-estrogens/bazedoxifene combination is a different option (TMS) | FDA-approved oral micronized progesterone, CombiPatch and Duavee exist; a levonorgestrel IUD and vaginal progesterone for menopausal endometrial protection are off-label in the U.S. | Agrees on the need for protection; alternatives need an individual plan | …that any progesterone cream or IUD protects the lining | "How will my lining be protected, and what if progesterone doesn't agree with me?" |
| 6. Vaginal estrogen | Describes a vaginal cream; calls genitourinary syndrome of menopause (GSM) the most undertreated problem (blog, Jun 2026) | Low-dose vaginal estrogen treats local symptoms with low absorption (TMS) | FDA-approved low-dose vaginal creams, tablets, inserts and a ring; urinary uses are off-label | Agrees | …that it treats hot flashes | "Is my main problem local, whole-body, or both?" |
| 7. Testosterone | Small amount of men's AndroGel, off-label, for bone and muscle rather than libido; monitors levels (blog, Jun 2026) | Best evidence is for distressing low sexual desire (HSDD) after assessment (ISSWSH 2021) | No FDA-approved testosterone for women; Schedule III; used off-label or compounded | Goes further | …that low energy or a low lab number means you need it | "What problem would it treat, and how will you keep me in the female range?" |
| 8. Estriol face cream | Daily, for skin thinning; cosmetic (blog, Jun 2026) | Not an established guideline treatment for menopause symptoms | FDA: marketed estriol drugs are compounded, not FDA-approved | Goes further (cosmetic use of a drug) | …that it's part of menopause treatment | "Is this compounded, and what is it for?" |
| 9. Vulvar DHEA | Describes a product for the vaginal opening as over the counter; also mentions prescription vaginal DHEA (blog, Jun 2026) | Prescription prasterone (Intrarosa), a vaginal insert, is FDA-approved for moderate to severe painful sex due to menopausal vulvovaginal atrophy | The OTC product she describes is not the FDA-approved prasterone vaginal insert | Her personal extra | …that OTC DHEA equals the prescription insert | "Would prasterone or vaginal estrogen fit my symptoms better?" |
| 10. No pellets, no sky-high testosterone | Warns pellets can push levels far above the female range (ABCs; Couric Q&A, May 2025) | ISSWSH does not recommend testosterone pellets or compounded testosterone for HSDD; TMS does not find compounded hormones safer or more effective than approved products | No testosterone pellet is FDA-approved for use in women; compounded pellets are not FDA-approved products | Agrees | …that "bioidentical" means approved | "Is anything you're offering a pellet or compounded?" |
| 11. If hormones aren't right | Covers non-hormonal options (E142, Jun 2026) | ACOG's Oct 2026 announcement includes SSRIs/SNRIs and neurokinin receptor antagonists among evidence-based non-hormonal options | FDA-approved for menopausal hot flashes: fezolinetant (Veozah), elinzanetant (Lynkuet), paroxetine 7.5 mg | Agrees | …that there's nothing left if you can't take estrogen | "Which non-hormonal option fits me, and what monitoring does it need?" |
How to read it: "Agrees" means the piece is standard care for the right person. "Goes further" means evidence is limited, guidance differs, or the goal is outside routine menopause care. Ask what problem it solves for you, and what supports using it for that problem.
Product status sources: FDA, Menopause & Hormones: Common Questions; FDA testosterone information; Intrarosa label; Prometrium label; CombiPatch label; Duavee label; Veozah label; Lynkuet label; Brisdelle label. These establish product or use status, not what a telehealth service will dispense.
Understanding Dr. Haver's advice is one step. Finding care that fits you is another. The right online menopause care isn't the same for every woman — it depends on your symptoms, what you've already tried, your age, your state and your health history. Some situations belong with an in-person clinician first. Use The HRT Index's Find My HRT Path tool to explore a featured care option for your situation — and to flag when online care isn't the right starting point — before your first consult.
It's free, takes about 60 seconds and doesn't ask for your email. It shows featured options, not every provider; compensation affects their order. It doesn't diagnose anything or decide whether you should take hormones. A clinician does that. See what the tool does and doesn't do.
What HRT does Dr. Mary Claire Haver take herself?
In her June 2026 podcast show notes and blog, Dr. Haver describes seven hormone products: an estradiol patch, a small nightly oral estradiol dose, nightly oral micronized progesterone, a small off-label amount of testosterone gel, vaginal estradiol cream, an estriol face cream and a vulvar DHEA product. She says she manages all of it with her own clinician.
Here's the list in plain words, with her reason for each. We've left out dose amounts and instructions to copy on purpose. Her doses fit her body, her labs and her history, not yours.
| What she uses | What kind of treatment it is | Her stated reason |
|---|---|---|
| Generic estradiol patch | Systemic estrogen | Steady dose, avoids the liver's first-pass processing, affordable |
| Small oral estradiol dose at night | Systemic estrogen | Her blood levels on the patch alone were below the range she wants for bone; she says this isn't for everyone |
| Oral micronized progesterone | Progestogen | Protects the uterine lining; she credits it for better sleep |
| Testosterone gel (AndroGel), off-label | Androgen | Started for bone and muscle, not libido |
| Vaginal estradiol cream | Local estrogen | Vaginal and urinary health |
| Estriol face cream | Cosmetic | Skin thinning |
| Vulvar DHEA (over the counter) | Local | Tissue at the vaginal opening |
Source: The 'Pause Life, June 26, 2026 (updated August 6, 2026); unPAUSED E142 show notes, June 16, 2026.
Micronized just means the progesterone is ground into very tiny particles so your body can absorb it well. FDA-approved oral capsules exist; the word alone does not verify a compounded capsule. (Prometrium label)
Her published routine changed between 2025 and 2026
In a May 2025 Q&A, Dr. Haver listed a patch, nightly oral micronized progesterone, AndroGel on her forearm, an estriol face cream she said she got from Alloy, and vaginal estrogen cream two to three times a week. (Katie Couric Media, May 6, 2025)
Her June 2026 account also includes the small oral estradiol dose. In a March 2026 essay she explains why. Her patch had controlled her hot flashes, but when she checked her blood, her estradiol was about half of the level she believes protects bone. Her words: "I got my own estrogen dosing wrong." (Substack, March 3, 2026)
That's the most useful part of her story. Even an expert's plan gets adjusted over time. So when you see "what Dr. Haver takes," treat it as a dated snapshot, not a recipe.
What she says to avoid
She is firm about two things. She cautions against testosterone pellets, which she says can push levels far above the normal female range. And in her 2025 Q&A, she said anyone routinely dosing women well above female ranges doesn't understand women's hormones. (The ABCs of Hormone Therapy; Katie Couric Media)
She doesn't want you to copy her list
Her own team calls her routine a philosophy, one that "isn't a checklist to replicate." Her point is to know what each treatment does and why, check what's actually happening in your body, and work with a clinician. (The 'Pause Life)
Should you copy Dr. Haver's HRT routine?
No, and she says so herself. Use the core pieces as a starting point for a conversation, and turn her extras into questions rather than requests. Your uterus, age, time since menopause, health history, insurance and goals decide what fits.
Here's a 30-second self-check. Nobody sees your answers but you. Each one points you to a different next step.
- Do you still have a uterus? If yes, systemic estrogen needs a plan to protect the lining. If no, that reason for progesterone usually goes away.
- Are you under 60, or within 10 years of your last period? If yes, you're in the window where guidelines are most supportive when there are symptoms to treat and no contraindications. If not, it's still a real conversation, just a more careful one.
- Have you ever had unexplained bleeding, a blood clot, stroke, heart attack, breast or uterine cancer, or liver disease? If yes, start with an in-person clinician. Online care and quizzes can't clear those.
- Do you want your insurance to pay? If yes, start with an in-network clinician, or Midi if it accepts your specific plan. Midi does not accept Medicare-related plans or Medicaid. If you're paying cash or with an HSA/FSA card, compare the complete cash quote with your own covered costs.
Already doing well on treatment? Then ask yourself one more question: is there a problem you want help with, or are you mostly worried because someone else takes more? If it's the second, you probably need reassurance and your normal follow-up, not a new plan. Another person's newer routine is not, by itself, a reason to change yours.
A worked example (made up, not a real patient)
Dana is 51. Her last period was 14 months ago. She has a uterus, night sweats and vaginal dryness. She has none of the red flags above, and she has a high-deductible health plan.
Using the Translator, Dana's first discussion list is short: whether systemic estradiol (row 2), uterine protection if it is prescribed (row 5), and local vaginal estrogen (row 6) fit her symptoms. Her next questions are whether a blood test would change anything (row 4), and whether testosterone makes sense for a specific problem (row 7). She doesn't add face cream or DHEA to her list just because Dr. Haver uses them.
Because she's paying out of pocket until her deductible, a flat cash plan may cost her less than a specialist visit plus pharmacy. That points her to the cost math below.
How to get HRT like Dr. Haver recommends if you can't see her
Dr. Haver's clinic, The 'Pause Wellness in Galveston, only treats Texas residents, including virtual visits for Texans, and it doesn't bill insurance. Everyone else can use a Menopause Society Certified Practitioner, their own doctor, or a telehealth service. Her site names Midi and Alloy, and we also compare Gala, our featured cash-pay option for women who want to discuss the core pieces—provided the exact medications and full quote fit.
A few facts surprised us, so here they are up front.
- Her clinic is Texas-only. Its FAQ says its clinicians are licensed in Texas and can only start and continue care for Texas residents. Out-of-state women are pointed to her list of recommended clinicians. (The 'Pause Wellness FAQ, checked October 15, 2026)
- Her website recommends two online menopause-care companies, with affiliate links. Her telemedicine page lists Midi and Alloy, and her blog posts that name them carry an affiliate-link note. (The 'Pause Life favorites; ABCs of Hormone Therapy) That's normal and disclosed. We earn from Gala. You deserve to know both.
- Gala is not on the list we checked. We recommend considering it for a specific reader, explained below, based on our own review—not a claimed endorsement from Dr. Haver.
Who provides which piece (checked October 15, 2026)
| Route | Best for | Estradiol / progesterone / vaginal estrogen | Testosterone | Estradiol blood tests | Insurance | Things to know |
|---|---|---|---|---|---|---|
| The 'Pause Wellness (Dr. Haver's clinic) | Texas residents who want her team | HRT assessment after a one-hour visit; ask about each medicine; prescriptions cost extra | Not confirmed; ask | Bloodwork included in the advertised visit package; confirm exact tests | No; HSA/FSA may be usable; CareCredit offered | Texas residents only. We could not confirm the visit price. Its FAQ says it does not provide traditional well-woman exams. |
| Menopause Society directory or Dr. Haver's clinician list | Anyone who wants to find in-person care | Depends on the clinician | Depends | Depends | Varies; confirm network status | Free to search. A listing isn't an endorsement. |
| Midi Health (on her list) | A covered insurance plan; scheduled video visits; interested in discussing testosterone | Prescriptions to your pharmacy; lists FDA-approved bioidentical options | Advertises compounded testosterone in 25 states, from $100 per 90-day supply; visits/labs separate | Testosterone monitoring is described; estradiol testing needs discussion | Many PPO plans; no Medicare-related coverage; no Medicaid/Medi-Cal, even self-pay | Self-pay $250 first visit, $150 follow-up. Confirm your state and plan. Compounded testosterone differs from Dr. Haver's off-label men's gel. |
| Alloy (on her list) | Wants to see product forms and prices first | Pill from $39.99/mo, gel $69.99/mo, spray $69.99/mo, patch $100/mo; progesterone from $23/mo; vaginal cream $119.97 per three-month tube | Not listed on the HRT menu checked | Its HRT help center says it does not order or facilitate bloodwork | Does not bill insurance; possible reimbursement depends on your plan | $49 one-time HRT consult; medicines are offered in three-month supplies. Final bundle price needs confirmation. Dr. Haver said in 2025 she got her estriol cream there. |
| Gala (our featured cash-pay option) | Cash or HSA/FSA; wants online review and ongoing messaging | Lists estradiol pill or patch, progesterone, vaginal estradiol and non-hormonal options; exact finished products unnamed | Not listed on the HRT pages checked | Usually not needed, per Gala; confirm testing and lab fees if relevant | No | $69/mo advertised as flat; whether multiple medicines are included together is unconfirmed. HRT age/state availability needs checking. |
| Your own OB-GYN or primary care doctor | You already have a clinician who knows you | Discuss which options the clinician prescribes and your pharmacy can fill | Depends on the clinician | If clinically useful and ordered | Depends on network and plan | Bring the worksheet below; a new provider may not be necessary. |
Source: The 'Pause Wellness; Midi HRT, Midi pricing and Midi testosterone; Alloy HRT, progesterone and vaginal cream; Gala hormone health; Gala $69 HRT page. Provider-published information, checked October 15, 2026; a listed medicine is not a promise to prescribe it. See also Alloy’s lab policy and insurance policy.
Why Gala is our pick for cash-pay women who want to discuss the core
If you're paying cash and want to discuss what Dr. Haver calls the foundation—estrogen, uterine protection when needed, and vaginal estrogen for local symptoms—Gala is worth considering. Its menu covers those options, and its advertised $69 monthly plan includes ongoing care. The important limit: the public pages do not establish that all three medicines are included together for $69.
Here's the evidence.
- It lists every core piece. Gala's HRT pages list an estradiol pill or patch, oral progesterone, vaginal estradiol cream or tablet, and non-hormonal options. Gala says a clinician chooses the form based on your symptoms and history; the menu is not a prescription guarantee. (Gala, October 15, 2026)
- One advertised price. Gala's HRT page advertises $69 a month, flat, with no membership fee, no insurance billing and no price increase when your dose changes. It says your exact plan and price show before you pay. (Gala $69 page, October 15, 2026)
- The price question matters most if you need two medicines. Most women with a uterus who use systemic estrogen also need a progestogen. Ask whether the $69 covers your exact estrogen and uterine-protection plan together, and whether local vaginal treatment costs extra. The answer decides whether the headline price is useful to you.
- Ongoing care is advertised as included. Gala says provider messaging, symptom check-ins and dose adjustments continue for as long as you're treated, with free shipping and support seven days a week.
- It covers perimenopause. Gala says its plans are built for the years before and after the final period, not only after menopause.
- It accepts HSA and FSA cards.
Gala publishes patient stories. One, from a woman Gala identifies as Allison, 51, says "Gala's provider walked me through the options." Gala chose and posted that quote, so treat it as a description of the service, not proof of results. (Gala)
Where Gala is the wrong fit, plainly:
- You want insurance to pay. Gala is cash-pay. Start with an in-network doctor, or Midi if it accepts your specific insurance plan. Midi is not a covered Medicare or Medicaid route.
- You want testosterone. Gala's HRT pages don't list it. Midi advertises compounded testosterone in 25 states; ask your own clinician about other options, including an approved product used off-label. These are not equivalent prescribing routes.
- You want your estradiol level checked, like Dr. Haver does. Gala's FAQ says labs are usually not needed, although another answer mentions symptoms and labs. Before paying, ask whether testing would be clinically useful in your case, whether Gala can order it, and who pays.
- You need a named FDA-approved product confirmed before you pay. Gala's HRT pages describe FDA-approved forms, but don't identify the products or makers. Ask which exact finished product you'd get. Alloy's product pages offer more detail on forms and prices, but you should still confirm the manufacturer and prescription rather than infer approval from the word bioidentical.
- Cancel terms need a screenshot. Gala's HRT page says cancel anytime from your account, but the shared refund policy linked from that page (dated February 2026) sets a 72-hour cutoff before billing and generally excludes refunds for cancellation. Its medical-disqualification refund wording is not consistent. Ask which HRT agreement applies, what is charged when you submit intake, and how to obtain written cancellation confirmation. Its GLP-1-branded terms are not proof of HRT-specific inclusions.
If you want to discuss the core options, you're paying cash, and you don't need an in-person assessment first, Gala is worth a look. Before paying, ask: Which exact medicines and makers are included, what is due today and at renewal, are labs extra, and does the 72-hour cancellation cutoff apply? Keep the worksheet below open.
Affiliate link. This is The HRT Index's recommendation for the reader described above, not a recommendation attributed to Dr. Haver.
Need something else? If insurance comes first, check whether Midi takes your plan. If you want to see product forms and prices before you start, look at Alloy's published HRT menu. If you live in Texas and want Dr. Haver's own clinic, request a visit at The 'Pause Wellness. We earn nothing from these three links.
Before choosing Alloy: Its HRT help center says it does not order or arrange bloodwork, so it is not a route for Dr. Haver-style estradiol testing. Its products generally come in three-month supplies; the help center asks for at least seven days’ notice for subscription changes. Orders already processing cannot be canceled, and products cannot be returned. Check each prescription in a bundle when canceling. (Labs; supply and change notice; cancellation; returns)
What does a Haver-style core plan cost in the first 90 days?
Three advertised $69 Gala charges total $207, but that is not a confirmed 90-day quote for estradiol plus progesterone. Alloy's separate starting prices add up to $237.97 with a pill or $418 with a patch, including its $49 consult. Those are catalog calculations, not verified bundle quotes. With insurance, your covered visit and pharmacy costs decide it.
| Route | Due to start | Recurring amount / supply | First-period calculation—not a complete quote | Add vaginal estrogen | Add testosterone | What's unknown |
|---|---|---|---|---|---|---|
| Gala | $69 advertised monthly fee; confirm the exact amount and charge timing before submitting intake | $69/month advertised; actual renewal dates unconfirmed | $207 = $69 × 3 advertised charges. Medication combination and exact first-90-day cash flow unconfirmed | Listed; whether included with the other medicines is unconfirmed | Not listed in the HRT offer | Exact products; bundle inclusions; lab charges; billing interval and applicable HRT cancellation terms |
| Alloy, pill | $49 consult, plus the accepted medicine order; separate-item three-month model adds $188.97 | Pill from $39.99 + progesterone from $23 per month equivalent; three-month supplies | $237.97 = $49 + ($39.99 + $23) × 3, only if both separate starting prices apply | Standalone three-month tube $119.97; confirm combination/bundle pricing | Not listed on HRT menu | Final dose/product and bundle price; exact charge dates; care or tests arranged outside Alloy |
| Alloy, patch | $49 consult, plus the accepted medicine order; separate-item three-month model adds $369 | Patch $100/mo equivalent, shipped/billed every three months; progesterone from $23/mo equivalent | $418 = $49 + ($100 + $23) × 3, only if both separate prices apply | Standalone three-month tube $119.97; confirm combination/bundle pricing | Not listed on HRT menu | Whether your prescribed bundle changes these prices; subsequent refill dates; care or tests outside Alloy |
| Midi, self-pay | $250 first visit | $150 per follow-up; medicines and labs separately billed | $400 in visits if you have one follow-up, plus pharmacy and any labs | Pharmacy price | From $100 per 90-day supply of compounded medication, plus visits/labs | Pharmacy cost; lab cost; number and timing of visits; state availability |
| Midi or your doctor, insured | Your copay or deductible | Copay + pharmacy | Depends on your plan | Depends | Depends | Your plan's terms |
| The 'Pause Wellness (Texas) | Visit/package fee not confirmed; prescriptions separate | Follow-up and prescription charges depend on plan | Visit/package fee + pharmacy; complete total unknown | Pharmacy price | Ask | Visit price, exact tests and follow-up charges |
Prices checked October 15, 2026: Gala; Alloy's pill, patch, progesterone and vaginal cream; Midi. Alloy's pill and progesterone figures are starting prices, and adding their separate list prices does not prove a final bundle price. First-order promo codes are left out on purpose, because a promo changes one bill, not your plan. These are illustrative examples, not quotes.
How to read this table:
- "Due to start" separates the consult from the medicine order. At Alloy, the $49 consult is not the whole amount needed to obtain a three-month supply. Confirm the accepted order total and whether progesterone is included or added.
- The billing interval matters. Three calendar months, 90 days and three charges are not always the same. A hypothetical 28-day plan starting on day 0 would charge on days 0, 28, 56 and 84—four charges in the first 90 days. We did not confirm 28-day billing for Gala, so we do not present that as its price. Ask for actual renewal dates.
- Unknown means unknown. If a row leaves pharmacy, labs or bundle inclusions unresolved, the number shown is not a complete total. Do not rank it as the cheapest complete plan.
A worked comparison (hypothetical): A woman with a uterus wants to discuss a patch plus progesterone and pays cash. Alloy's separate-item calculation is $418 for the initial consult and three-month supply. Three Gala charges total $207, if $69 covers her prescribed patch and progesterone with no required extras. The arithmetic difference is $211, but it is not verified savings: she still needs matching products, confirmed bundle prices and actual renewal dates. If she also needs vaginal estrogen, Alloy's standalone three-month tube adds $119.97 to that separate-item example, bringing it to $537.97; Gala's combination price remains unconfirmed.
If you'd like to explore a single monthly care plan, check Gala's current price and plan, confirm the full medication quote, and screenshot the checkout page before you pay.
For more providers and insured-vs-cash math, see what HRT costs in 2026.
Why does Dr. Haver favor a patch and micronized progesterone?
A patch delivers estrogen through the skin, avoiding the liver's first-pass processing before it reaches the circulation; it may carry a lower blood-clot risk than pills. Micronized progesterone can protect the uterine lining when prescribed in an adequate regimen with systemic estrogen. FDA-approved products exist for both, but neither is the only good choice. (The Menopause Society)
A patch can be a good option without being the only one
Dr. Haver uses a generic patch as her main estrogen for three reasons: a steady dose, avoiding that first pass through the liver, and cost. That matches what The Menopause Society says, carefully: clot risk may be lower with estrogen through the skin, such as a patch, gel or spray. "May be" is the honest wording. It isn't zero.
The Menopause Society's position statement says approved oral and transdermal products are highly effective for hot flashes. That supports discussing a patch, not claiming it is the best route for every woman. (TMS 2022)
Still, the best route for you depends on real-life things too: Does adhesive irritate your skin? Will you remember a twice-weekly change? Does your pharmacy have your patch in stock? Does your insurance cover it?
About patch supply: The FDA said on September 3, 2026 that it was working with all six estradiol patch manufacturers to increase supply after demand rose following its November 2025 labeling action. It said patches remained available, though particular products or brands could vary by pharmacy. (FDA update) That dated national update is not a live stock check. If you can't fill yours, talk with your prescriber and pharmacist before changing anything. Don't swap products or doses on your own.
Progesterone protects the lining in the right regimen
If you have a uterus and take systemic estrogen, estrogen without adequate uterine protection can thicken the lining and raise the risk of uterine cancer. A progestogen in the right regimen reduces that risk. This is one of the clearest rules in menopause care, and Dr. Haver calls her nightly progesterone the one thing she'd never skip.
What her sources and the guidelines add:
- FDA-approved oral micronized progesterone capsules are available. Many women take it at bedtime because it can make them sleepy. Dr. Haver credits it for her sleep.
- If progesterone doesn't agree with you, she lists alternatives: vaginal use, a hormonal IUD, CombiPatch (estradiol and norethindrone acetate in one patch) or Duavee (conjugated estrogens with bazedoxifene). Duavee is a different complete regimen, not something to add to your existing estrogen; its label says not to add estrogens or progestins. A levonorgestrel IUD and vaginal progesterone for menopausal uterine protection are off-label in the U.S., with limited evidence for some uses. Your clinician must choose an adequate regimen rather than assume any IUD or vaginal product will do. (TMS 2022; CombiPatch; Duavee)
- Not every progesterone product protects the lining. An over-the-counter or compounded progesterone cream is not proven to do that job.
- No uterus? The main reason for progesterone usually goes away after a hysterectomy. Dr. Haver says some women without a uterus may still consider it for other reasons, like sleep. That's a separate decision with your clinician, not a standard need.
Bleeding note: Unexpected bleeding after menopause needs assessment. If you bleed in a way you didn't expect after starting HRT, tell your clinician rather than waiting it out; timing and persistence help determine the evaluation. (The Menopause Society)
Bioidentical doesn't mean compounded
"Bioidentical" describes the shape of the molecule. It means the hormone matches what your body made. It says nothing about FDA approval.
Many FDA-approved products are bioidentical, including estradiol patches and pills and micronized progesterone capsules. Many compounded products are too. Compounded means ingredients are combined or altered to make a preparation for a particular medical need. The FDA says many products marketed as "bioidentical hormones" are compounded drugs, which are not FDA-approved. (FDA, Menopause)
The Menopause Society puts it plainly: "Custom-compounded hormones are not safer or more effective than approved bioidentical hormones." (The Menopause Society)
So whenever a menu just says "estradiol," ask: What's the exact product and maker? Is it FDA-approved or compounded? More detail in compounded vs FDA-approved HRT and our FDA-approved HRT medication list.
Does Mary Claire Haver recommend hormone blood tests?
Yes. In a March 2026 essay, Dr. Haver argues for checking estradiol levels after hormone therapy starts, and she openly disagrees with current guidelines. The Menopause Society's 2022 statement says serum hormone testing is rarely needed and that saliva and urine tests are unreliable for dosing.
What she argues
Her case goes like this. Guidelines were written to dose for symptoms: if hot flashes stop, the dose is right. But she says bone, heart and metabolism may need higher estradiol levels than symptom relief does, and skin absorption varies from woman to woman. So she checks a blood level once a patient has been on a steady dose for several weeks, and she suggests asking for a specific, more precise lab method called LC/MS. (Substack, March 3, 2026)
She also acknowledges the other side. Hormone levels swing, especially in perimenopause, and one blood draw is a snapshot.
What the guidelines say
The Menopause Society's 2022 position statement says saliva and urine tests to set doses are unreliable and not recommended, and that serum hormone testing is rarely needed. Doses, forms and routes should be set individually and reviewed over time. (TMS 2022, full statement)
Why there's no magic number to chase
There is no universally established blood estradiol target that proves your bones are protected. Levels vary with timing, the product, and the lab. The British Menopause Society's July 2025 review specifically says the lower blood-level threshold for bone benefit is uncertain. Bone health also involves bone density and personal risk factors. So one number can't tell you, by itself, that you're protected or that your dose must go up. (BMS review)
That doesn't make a test useless. "Rarely needed" is not "never useful." A test can help answer a specific question, like whether you're absorbing a patch when symptoms aren't improving.
How to talk about it with your clinician
A disagreement about testing doesn't mean you're being dismissed, or that your clinician is out of date. Try this:
"I read Dr. Haver's explanation about estradiol levels. In my situation, would measuring a level change what you'd recommend? If not, what will we use to judge whether my treatment is working?"
If testing matters to you, ask what clinical question it would answer, whether the service can order it, and who pays. If your symptoms aren't improving, our guide to signs your HRT dose may be too low can help you describe what's happening.
Still sorting out where to discuss these questions? Your clinician, not a quiz, decides which medicines or tests fit you. The HRT Index's Find My HRT Path tool helps with the care-navigation step: it asks about your symptoms, what you've tried, your age, your state and your health history, then shows a featured care option, or guidance when online care isn't the right place to start.
What does Dr. Haver say about testosterone for women?
Dr. Haver uses a small amount of a men's testosterone gel, off-label, mainly for bone and muscle, and she monitors her levels and warns against pellets. The strongest clinical support for testosterone in women is for distressing low sexual desire after a full assessment, not for energy, muscle, brain fog or aging.
Her reasoning
She says she started testosterone not for libido but because women with naturally higher testosterone tend to have better bone density and muscle. Libido was a bonus. She uses men's AndroGel off-label because the U.S. has no testosterone product approved for women. (The 'Pause Life, June 2026)
Here's the catch. A link between natural testosterone levels and stronger bones doesn't prove that prescribing testosterone builds bone or muscle. That hasn't been shown in the way it has for libido.
What the evidence supports
The International Society for the Study of Women's Sexual Health (ISSWSH) guideline recommends systemic testosterone through the skin for postmenopausal women with hypoactive sexual desire disorder (HSDD). HSDD means low sexual desire that causes you distress and isn't mainly explained by something else, like pain, medicines, mood or relationship stress. The same guideline says a testosterone blood level should not be used to diagnose HSDD, only as a starting point for monitoring, and that treatment should keep levels within the normal range for premenopausal women. (ISSWSH 2021)
In short: a low lab number isn't a diagnosis, and low energy isn't HSDD. Long-term safety has not been established; monitoring does not turn broader bone, muscle or anti-aging claims into proven benefits.
Off-label is different from compounded
- Off-label means a clinician prescribes an FDA-approved product for a use or person the label doesn't cover, like a men's gel at a small dose for a woman.
- Compounded means a pharmacy makes a custom product that isn't FDA-approved.
Both happen with testosterone for women, but they are not equivalent choices. ISSWSH does not recommend compounded testosterone for HSDD because efficacy, safety and product consistency are not established. Midi says it uses compounded testosterone, with testing at baseline, 4 to 6 weeks, then every 6 to 12 months, and no pellets. That is Midi's published service protocol—not an endorsement of compounding by the guideline. Ask about an approved men's product used off-label when that is the route you want to discuss. (ISSWSH; Midi, checked October 15, 2026)
Testosterone is a Schedule III controlled substance in the U.S. and needs a prescription. AndroGel's label carries a boxed warning about secondary exposure: children and others can absorb testosterone from skin contact, which can cause unwanted effects. (AndroGel label, DailyMed) We won't give dose conversions or application amounts. That's for your prescriber.
Questions to ask about testosterone safety
- "What specific problem would this treat, and what evidence supports it for that problem?"
- "How will you keep my level within the normal female range?"
- "What side effects should I watch for, like acne or hair changes?"
- "When will we decide whether it's worth continuing?"
- "Is this an approved product used off-label, or compounded? Is it a pellet?"
What about vaginal estrogen, estriol face cream and DHEA?
These aren't one kind of treatment. FDA-approved low-dose vaginal estrogen products treat local vaginal symptoms and may also help certain urinary problems. Estriol face cream is a cosmetic use of a drug; the FDA says marketed estriol drugs are compounded, not approved. An over-the-counter DHEA product is different from the prescription vaginal insert prasterone.
Vaginal estrogen treats a different problem than hot flashes
Genitourinary syndrome of menopause (GSM) is the name for dryness, burning, pain with sex and urinary symptoms caused by low estrogen in the vaginal and urinary tissues. Dr. Haver calls it the most undertreated part of menopause, and she uses a vaginal estradiol cream twice a week. She also says it can help prevent urinary tract infections. (The 'Pause Life)
Low-dose vaginal estrogen comes as FDA-approved creams, tablets, inserts and a ring. The Menopause Society notes it's absorbed in only small amounts. A progestogen is generally not needed with low-dose local treatment, although trial data on the uterine lining beyond a year are limited; unexpected bleeding still needs assessment. It won't fix hot flashes. Vaginal estrogen can help reduce recurrent urinary tract infections in suitable postmenopausal women, but that urinary use is off-label—not an FDA-approved indication. Some vaginal products deliver systemic estrogen, so check the exact product. Many women need only local treatment, and some need both local and systemic treatment. (TMS 2022) Our vaginal estrogen guide compares the options.
If you've had breast cancer, local treatment is still sometimes possible, but that decision belongs with your oncology team.
Estriol face cream is cosmetic, and compounded
Dr. Haver uses an estriol cream on her face for skin thinning. Estriol is a weaker estrogen. The FDA says plainly: "Marketed drugs that contain estriol are compounded drugs, which are not FDA-approved." (FDA, Menopause & Hormones: Common Questions) This is a compounded drug used for a cosmetic goal, not a required menopause treatment. Alloy currently lists its prescription M4 face cream at $150 for a three-month supply, with doctor access and shipping included; that verifies the advertised offer, not its outcome claims or that it is the same formulation she received in 2025. (Alloy M4, checked October 15, 2026)
OTC DHEA isn't the same as prescription prasterone
DHEA is a hormone your body can turn into estrogen and testosterone. Dr. Haver describes a DHEA product for the tissue at the vaginal opening as over the counter, although her blog's product note says it is in development. That does not establish a product you can buy now. Separately, prasterone (Intrarosa) is an FDA-approved vaginal insert for moderate to severe painful sex due to menopausal vulvovaginal atrophy. (Intrarosa label) It is not an interchangeable prescription version of an OTC vulvar product. If pain with sex is your main problem, ask: "Would prasterone or vaginal estrogen fit me better?"
What can HRT help, and what shouldn't it promise?
Hormone therapy is the most effective treatment for hot flashes and night sweats, it helps sleep disrupted by them, and it prevents bone loss in the right patients. It isn't a proven plan to prevent dementia, and it isn't a weight-loss or anti-aging treatment.
What major guidance supports
ACOG's October 15, 2026 announcement describes hormone therapy as an important option for hot flashes and related sleep disruption, with initiation based on shared decision-making. If it is chosen, ACOG recommends starting before age 60 or within 10 years of natural menopause in people without contraindications. Your symptoms, history, cardiovascular and breast-cancer risks, and treatment goals all belong in that conversation. (ACOG's own announcement)
Hormone therapy is not a substitute for depression care. The Menopause Society's statement distinguishes possible mood effects during perimenopause from treatment of a depressive disorder; women whose main problem is depression need an assessment and appropriate depression treatment. (TMS 2022)
Where Dr. Haver goes further
Dr. Haver often talks about long-term protection for bones, heart and metabolism. Some of that is supported: the FDA's February 2026 announcement describes randomized studies showing lower overall death rates and fewer fractures in women who started HRT within about 10 years of menopause. (FDA, Feb. 12, 2026)
But The Menopause Society's 2022 statement says hormone therapy is not recommended at any age to prevent or treat declining memory or dementia. (TMS 2022, full statement) HRT is also not recommended solely to prevent heart disease. So "symptom relief and bone protection in the right patient" is solid ground. "It prevents every disease of aging" is not.
What changed in the FDA warnings
- November 10, 2025: The FDA requested changes to boxed-warning language on menopausal hormone therapy labels; an announcement did not instantly change every label. It did not seek to remove the endometrial-cancer boxed warning for systemic estrogen-alone products. (HHS announcement; FDA explanation)
- February 12, 2026: The FDA approved the first six relabeled products, removing boxed statements about heart disease, breast cancer and probable dementia. Twenty-nine companies had submitted changes, so not every label changed at once. (FDA)
A lighter warning box doesn't mean risk-free. Risk information still sits on the label, and compounded products weren't part of this change. One more fact, since people ask: Dr. Haver has long pushed for this kind of change, but she was not one of the 12 named panelists at the FDA's July 17, 2025 expert panel. (FDA panel page)
A claim that every estrogen product still has the same boxed warning is now out of date. Check the FDA's list of updated prescribing information and the label for the specific product—not a general statement about all estrogen. More in our 2026 label changes explainer and HRT benefits and risks.
Which parts of her advice could apply to your situation?
The question isn't whether you're enough like Dr. Haver to copy her plan. It's which questions matter for your symptoms, menstrual stage, uterus, health history and goals. These situations change the answer most.
Still having periods (perimenopause)
You don't have to wait until your periods stop to talk about treatment. Dr. Haver's newest book, The New Perimenopause (April 2026), is about exactly this stage. But two extra questions come up: Could you still get pregnant, and do you need birth control? HRT itself is not contraception. And because hormone levels swing so much in perimenopause, single blood tests are especially hard to read. (NHS guidance) Our perimenopause symptoms checklist helps you track what's happening before a visit.
Starting HRT after 60
Dr. Haver's site says hormone therapy may still be an option after 60 with a careful, individual discussion. That matches The Menopause Society's guidance, which treats starting later as a closer look, not an automatic no. Starting later can have a less favorable balance because absolute risks of coronary heart disease, stroke, blood clots and dementia are higher. Starting after 60 is also a different question from continuing a treatment you started earlier. Some online services set age limits, so confirm before you sign up. (TMS 2022)
Early menopause or ovaries removed before the usual age
This is a different clinical situation from starting hormones many years after natural menopause. When ovarian function is lost early, The Menopause Society generally recommends hormone therapy until around the usual menopause age, unless there is a contraindication. The cause, fertility and contraception needs, and your own risks need a clinician's review; don't apply a public figure's midlife regimen to yourself. (TMS 2022)
Medical history that changes the starting point
Start with an in-person clinician if you have:
- Unexplained vaginal bleeding
- A history of blood clots, stroke or heart attack
- Breast or uterine cancer
- Liver disease
These are among the reasons The Menopause Society lists for avoiding systemic hormone therapy or seeking specialist assessment first. A patch is not an automatic workaround for these histories: the contraindications apply to oral and transdermal systemic treatment. Decisions about low-dose local vaginal treatment are different, including sometimes involving an oncology team. No article, and no quiz, can clear you for hormones. See HRT contraindications and HRT and breast cancer risk. To search for menopause care near you, use The Menopause Society's directory and check the clinician's credentials and insurance. (TMS 2022)
If hormones aren't for you
You still have good options. ACOG's October 2026 announcement includes certain antidepressants—selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs)—and newer neurokinin receptor antagonists, medicines that act on brain pathways involved in hot flashes. Fezolinetant (Veozah) and elinzanetant (Lynkuet) are FDA-approved for menopausal hot flashes, but their liver-monitoring requirements differ. Veozah has a boxed liver-injury warning and requires testing before treatment, monthly for the first three months, then at months 6 and 9; Lynkuet's label calls for testing before treatment and at three months, with further evaluation if symptoms suggest liver injury. Paroxetine 7.5 mg is FDA-approved for hot flashes; that formulation is not approved to treat depression. ACOG says evidence does not support phytoestrogens or herbal supplements for these symptoms. (ACOG; Veozah label; Lynkuet label; Brisdelle label) See non-hormonal options.
My HRT appointment worksheet
The HRT Index · Editorial resource — not medical advice
What to bring to your appointment: a worksheet built from Dr. Haver's approach
Bring the problem you want help with, what you already use, and the questions that could change the decision. A focused note works better than asking for someone else's full routine. Dr. Haver's own advice when a clinician won't engage is to share what you've read and, if needed, find a different clinician.
You don't need perfect words or a long list of tests. Start with what's making life harder.
Part 1: Fill in on your own copy
| Topic | Prompt |
|---|---|
| My main concern | "The problem I most want help with is _. It affects my _ (sleep, work, relationships, mood)." |
| Timing | "It started about _. My periods have been . The pattern I notice is _." |
| What I already use | "My prescriptions, over-the-counter products, supplements and birth control are ____." |
| What has and hasn't helped | "I tried _. It helped with . The problem or side effect was _." |
| History to discuss privately | "I need you to know about _. I'm not sure whether _ matters." |
| My practical limits | "My insurance, pharmacy, preferred form (patch, pill, gel), budget and follow-up needs are ____." |
| My goal for today | "By the end of this visit, I want to understand or decide ____." |
Part 2: Questions to ask
| What you're deciding | Exact question |
|---|---|
| Is menopause the whole story? | "What else could explain my symptoms, and does anything need checking first?" |
| Is treatment right for me? | "What are the likely benefits and risks for me, including non-hormonal options?" |
| Which form? | "Why would you choose a patch, gel, spray, pill or local treatment for me?" |
| Do I need uterine protection? | "Does this plan need protection for my uterine lining, and how will it be provided?" |
| Would testing help? | "What would this lab test tell us, and how would the result change my care?" |
| Is testosterone relevant? | "What specific problem would it treat, and what evidence supports that use?" |
| What exactly would I get? | "What's the exact product, maker and form? Is it FDA-approved, off-label for this use, or compounded?" |
| What's the total cost? | "What's due today and at each renewal, including visits, medicines, labs and shipping?" |
| What happens next? | "When will we review how it's working, how do I reach you, and how do refills work?" |
| What if something changes? | "What should I do if my pharmacy can't fill it, my insurance changes, or I leave the service?" |
Complete this on your own paper or in your own notes; you do not need to send your answers to The HRT Index. Write “I'm not sure” wherever you need your clinician's help.
A second worked example (made up, not a real patient)
Rachel, 46, still has periods, wakes up soaked twice a week and has a doctor she trusts. After reading this page, she writes one line at the top of her worksheet: "I want to know if perimenopause explains this, what else needs checking, how birth control affects my options, and whether my insurance covers treatment." That's a better visit agenda, not a diagnosis or a product choice.
If your doctor says no
Being told no without understanding why is frustrating, and you're not wrong to want a real conversation. Dr. Haver's advice is to share what you've read, and if a clinician still won't discuss the risks and benefits, to look elsewhere: a Menopause Society Certified Practitioner, her list of recommended clinicians, or telehealth. (The 'Pause Life, "Misconceptions Around HRT")
Before you switch, it's fair to ask one question: "Is there a reason in my history that makes you hesitant?" Sometimes there is.
What supplements does Dr. Haver take with HRT?
In the show notes for her June 2026 podcast, Dr. Haver lists omega-3s, vitamin D, vitamin K, methylated B vitamins, CoQ10, genistein, collagen, creatine, fiber, magnesium L-threonate and a sleep supplement, plus oral minoxidil for hair. These are her personal choices, not part of HRT, and her company sells a supplement line.
A few plain facts to keep this in perspective:
- Supplements aren't FDA-approved for safety and effectiveness before they're sold. The FDA still regulates them; the rules are different from prescription-drug approval. (FDA)
- ACOG's October 2026 announcement says the evidence doesn't support soy-type plant estrogens or herbal supplements for menopausal symptoms. (ACOG)
- Oral minoxidil is a blood-pressure medicine some clinicians prescribe off-label for hair loss. It needs a prescription and a conversation about side effects. (MedlinePlus; her reported use)
- Her clinic's visit package includes a month of her company's supplements, which is worth knowing when you weigh her supplement advice. (The 'Pause Wellness)
Her show notes list her sources if you'd like to read them. (unPAUSED E142)
How we researched Dr. Haver's recommendations
We read Dr. Haver's own blog posts, essay, podcast show notes and clinic pages, plus a 2025 interview, and compared the claims with FDA announcements and labeling, The Menopause Society's position statement, a British Menopause Society estradiol-testing review, and an ISSWSH testosterone guideline. We read ACOG's own October 15 announcement about its new guidance, not the full guideline. Provider pages were rechecked on October 15, 2026. This is a review of documents, not a patient test or a medical review.
We use The HRT Index Verification Standard. Here's how its five pillars applied to this page.
| Pillar | How we applied it here |
|---|---|
| 1. Clinical legitimacy | We separated who said what: Dr. Haver's views, guideline positions, FDA approval status, off-label use and provider marketing. |
| 2. Care quality | We noted which routes advertise follow-up, messaging and lab monitoring, without claiming firsthand experience. |
| 3. Medication fit | We compared each piece by purpose, route and FDA-approved, off-label or compounded status, before any brand. |
| 4. Price transparency | We split amount due first, recurring charges and unknowns, and never counted an unknown as $0. |
| 5. Access | We checked state limits (her clinic is Texas-only), insurance rules (Midi's Medicare and Medicaid limits) and stated age or availability limits. |
We don't give scores. A made-up number would just be one more thing to second-guess. Read our full methodology, affiliate disclosure and medical review policy. This page is editorial research and was not reviewed by a clinician.
Mary Claire Haver HRT recommendations: quick answers
What is Dr. Mary Claire Haver's HRT protocol?
There isn't one regimen everyone should copy. Her June 2026 account includes an estradiol patch, oral micronized progesterone and vaginal estrogen, plus a small oral estradiol dose, off-label testosterone, estriol face cream and a vulvar DHEA product she describes. She ties those choices to her own symptoms, labs and goals. Your medicines may be different—or you may not need them.
Does Dr. Haver use a patch or a pill?
Her June 2026 account includes both. A twice-weekly generic patch is her main estrogen, and she describes adding a small nightly oral dose because her blood levels were lower than she wanted for bone. That is her personal rationale, not an established blood target everyone should chase.
Which estradiol patch brand does she recommend?
She describes using a generic patch and doesn't name one brand for everyone. Many FDA-approved patches exist, and the right one depends on your skin, budget, insurance and pharmacy stock.
Does Dr. Haver recommend testosterone for women?
She uses it herself, off-label, for bone and muscle. There's no FDA-approved testosterone for women, and the strongest evidence supports it only for distressing low sexual desire after a full assessment.
Do you need progesterone after a hysterectomy?
Usually not for uterine protection, because that's its main job. Other uses, like sleep, are a separate decision with your clinician.
Can I become a patient of Dr. Haver?
Her clinic, The 'Pause Wellness in Galveston, treats Texas residents only, including virtual visits for Texans. Visits are with her team of clinicians, and the clinic doesn't bill insurance.
Which telehealth companies does Dr. Haver recommend?
Her website lists Midi and Alloy for online menopause care, using affiliate links. Midi works with many PPO insurance plans but not Medicare-related plans or Medicaid; Alloy publishes cash product prices.
Is Gala recommended by Dr. Haver?
Gala is not on the telemedicine list we checked. It is The HRT Index's independent featured option for cash-pay women who want online care and whose final medication quote fits—not a recommendation we attribute to Dr. Haver. We earn a commission from Gala.
Can an online provider give me exactly her routine?
We did not verify a service that promises to reproduce her full routine, and a clinician—not a product menu—decides what's right for you. Some pieces, like estriol face cream and testosterone, aren't offered everywhere or use the same formulations.
Is HRT safe, according to Dr. Haver?
Her general guidance stresses individual treatment near menopause, without contraindications. Major guidance favors systemic HRT for appropriate symptoms before 60 or within 10 years of menopause, but that doesn't apply to everyone; certain histories need a clinician or specialist's review first.
Was Dr. Haver on the FDA's HRT panel?
No. She wasn't one of the 12 named panelists at the FDA's July 17, 2025 expert panel, though she supported the label changes that followed.
What books has Dr. Haver written?
The Galveston Diet, The New Menopause and The New Perimenopause, released April 7, 2026. (Her book page)
Bottom line: use her advice to start the conversation, then pick a route that can deliver it
Dr. Haver's HRT recommendations include mainstream options: estradiol, uterine protection when systemic estrogen is used with a uterus, and vaginal estrogen for local symptoms. Her extras fit her own account of her labs and goals, not a universal protocol. Your next step is choosing care that can assess which pieces, if any, you actually need.
- If you live in Texas and want her team, her clinic is an option.
- If insurance comes first, start with an in-network doctor, or Midi if it accepts your specific plan—not as a covered Medicare or Medicaid option.
- If you want to see product forms and prices first, Alloy publishes its menu; confirm the exact prescribed product and bundle.
- If you want to discuss testosterone or estradiol testing, choose a clinician who can explain whether it would help and provide appropriate monitoring—not one who simply agrees to copy the list.
- If you're paying cash and want online review with ongoing messaging, Gala is our featured option to consider. Confirm which medicines the $69 price includes, the exact finished products, any lab charges and the cancellation terms, then keep a copy of the checkout.
Affiliate link. A clinician decides whether any treatment is right for you; a prescription is never guaranteed.
Still deciding what kind of care fits you? You don't have to figure out the whole menopause-care market today. The free Find My HRT Path quiz asks five questions about your symptoms, what you've tried, your age, your state and your health history. Then it shows a featured care option, or guidance when online care isn't the right starting point. It's not a medical clearance test.
And if you already have a clinician who knows your history, bring the worksheet above. That's often the best first step of all.
Sources
Dr. Haver's own materials
- The 'Pause Life: Dr. Mary Claire Haver Breaks Down Everything She Actually Takes — published June 26, 2026; updated August 6, 2026; read October 15, 2026
- unPAUSED E142: Menopause Masterclass: My Menopause Toolkit – HRT and more — June 16, 2026; show notes read October 15, 2026 (audio not reviewed)
- Dr. Mary Claire Haver, "Why I Check Estradiol Levels After Hormone Therapy Begins" — March 3, 2026; read October 15, 2026
- The 'Pause Life: The ABCs of Hormone Therapy — updated March 19, 2026; read October 15, 2026
- The 'Pause Life: Misconceptions Around Hormone Replacement Therapy — updated June 16, 2026; read October 15, 2026
- The 'Pause Life: Telemedicine favorites — read October 15, 2026
- The 'Pause Wellness clinic and FAQ — read October 15, 2026
- Katie Couric Media: Dr. Haver Q&A — May 6, 2025; interview read October 15, 2026
- The 'Pause Life: The New Perimenopause book — April 7, 2026 release date listed on the author’s page; read October 15, 2026
Medical and regulatory
- ACOG: Expands Recommendations for Management of Menopause Symptoms — official announcement, October 15, 2026; read October 15. The full Clinical Practice Guideline No. 13 was not read.
- The Menopause Society: 2022 Hormone Therapy Position Statement, full text — relevant clinical sections read and checked against PDF page images October 15, 2026
- The Menopause Society: Hormone Therapy, patient education — read October 15, 2026
- British Menopause Society: Measurement of serum estradiol in the menopause transition — July 2025; relevant text and PDF pages checked October 15, 2026
- ISSWSH Clinical Practice Guideline: Systemic Testosterone for HSDD in Women, full text — 2021; relevant text and PDF page checked October 15, 2026
- FDA: Labeling changes for menopausal hormone therapy products — February 12, 2026; read October 15, 2026
- HHS: Action on FDA warnings for hormone replacement therapy — November 10, 2025; read October 15, 2026
- FDA: Hormone Replacement Therapies Can Help Women with Bothersome Menopausal Symptoms and updated prescribing-information hub — current warning context checked October 15, 2026
- FDA Expert Panel on Menopause and Hormone Replacement Therapy — July 17, 2025; named roster checked October 15, 2026
- FDA: Menopause & Hormones: Common Questions and FDA: Menopause — approval/compounding distinctions checked October 15, 2026; the older handout is not the source for 2026 warning changes
- FDA: Estradiol transdermal patch availability update — September 3, 2026; read October 15, 2026, not a pharmacy inventory check
- FDA: Testosterone information and DailyMed: AndroGel label — U.S. indication, prescription/controlled status and secondary-exposure warning checked October 15, 2026
- DailyMed: Prometrium, CombiPatch and Duavee — product/route/indication details checked October 15, 2026; not a claim that each label has already been revised under the 2026 initiative
- Intrarosa (prasterone) FDA prescribing information — November 2016 approval label, used for formulation and indication; page checked October 15, 2026
- Lynkuet FDA prescribing information — October 2025 label; liver-testing requirements checked October 15, 2026
- Veozah FDA prescribing information — December 2024 boxed-warning label; liver-testing requirements checked October 15, 2026
- DailyMed: Brisdelle — indication checked October 15, 2026
- NHS: When to take HRT — perimenopause and contraception points checked October 15, 2026; not used to establish U.S. product licensing
- FDA: Dietary supplements and MedlinePlus: Minoxidil — relevant regulatory and prescription-use information read October 15, 2026
Providers (prices are what each provider advertised on the date shown)
- Gala: Hormone Health, estradiol page and $69 HRT offer — read October 15, 2026; unnamed finished products and unconfirmed multi-medicine inclusions remain unresolved
- Gala: Terms and Conditions — September 22, 2026; read October 15. Refund policy — February 2026; read October 15. HRT-specific applicability and conflicting cancellation wording need confirmation.
- Alloy: HRT, pill, patch, progesterone, vaginal estradiol and M4 face cream — current menu, prices and stated supply periods read October 15, 2026; list-price addition is not confirmation of a personalized bundle
- Alloy help center: insurance, lab testing, pricing cadence, three-month supply/change notice, non-weight-care cancellation and returns — read October 15, 2026
- Midi Health: HRT and insurance, pricing and testosterone — read October 15, 2026; stated 25-state testosterone availability is not verification of every reader’s state
- The HRT Index: Gala Health HRT review — related editorial review read October 15, 2026; current commercial facts above were checked on provider pages rather than inferred from our earlier review
The HRT Index is an independent editorial publication. We are not a healthcare provider, pharmacy or telehealth service, and we are not affiliated with Dr. Mary Claire Haver. Nothing here is medical advice, a diagnosis or a treatment plan. For decisions about starting, stopping or changing hormone therapy, talk with a licensed clinician who knows your history. In an emergency, call 911.
Keep reading: Best online HRT providers · Gala vs Midi · Midi vs Alloy vs Winona vs Evernow · If your progesterone is out of stock
